Skip to main navigation Skip to search Skip to main content

Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study

  • Ryo Sawada
  • , Tadaaki Yamada
  • , Yasuhiro Goto
  • , Yoshiki Negi
  • , Akira Nakao
  • , Akihiro Yoshimura
  • , Naoki Furuya
  • , Tomohiro Oba
  • , Makoto Hibino
  • , Haruka Nakatani
  • , Hirokazu Taniguchi
  • , Aya Ohtsubo
  • , Satoshi Watanabe
  • , Takahiro Yamada
  • , Yusuke Chihara
  • , Takashi Kijima
  • , Koichi Takayama

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology